Cardinal Point Capital Management, Ulc Abbott Laboratories Transaction History
Cardinal Point Capital Management, Ulc
- $1.26 Trillion
- Q2 2025
A detailed history of Cardinal Point Capital Management, Ulc transactions in Abbott Laboratories stock. As of the latest transaction made, Cardinal Point Capital Management, Ulc holds 3,908 shares of ABT stock, worth $525,977. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,908Holding current value
$525,977% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,600Shares Held
1.4BCall Options Held
9.23MPut Options Held
8.1M-
Vanguard Group Inc Valley Forge, PA173MShares$23.3 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.4MShares$10.5 Billion0.41% of portfolio
-
Capital International Investors Los Angeles, CA60.1MShares$8.09 Billion1.47% of portfolio
-
Capital Research Global Investors Los Angeles, CA41.8MShares$5.62 Billion1.19% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $236B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...